is being presented by Dr. Anita S. Kablinger, Virginia Tech Carilion School of Medicine and airs on February 15th, 2011. For more details or to register, please visit our site at www.fxconferences.com
Clinical researchers face a steep learning curve. The importance of research, as well as the practice of participation in research, remains a relatively minor component of medical school and graduate medical education. Clinical investigators often have limited knowledge of the FDA rules and regulations in drug development other aspects of clinical research.
This presentation reviews the FDA guidance concerning what the clinical investigator – as well as those seeking qualified investigators – needs to know and demonstrate to provide academic rigor, maintain the highest safety standards of participants and promote the development of novel compounds and devices.
